{
    "xml": "<topic id=\"PHP85586\" outputclass=\"drug\" rev=\"1.26\" type=\"drug\" namespace=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\" basename=\"cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\" title=\"COBICISTAT WITH ELVITEGRAVIR, EMTRICITABINE AND TENOFOVIR\">\n<title>COBICISTAT WITH ELVITEGRAVIR, EMTRICITABINE AND TENOFOVIR </title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_998\" namespace=\"/interactions/list-of-drug-interactions/antivirals/emtricitabine\">Emtricitabine</xref>, <xref format=\"dita\" href=\"#bnf_int_954\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tenofovir\">Tenofovir</xref>, <xref format=\"dita\" href=\"#bnf_int_1259\" namespace=\"/interactions/list-of-drug-interactions/cobicistat\">Cobicistat</xref>, <xref format=\"dita\" href=\"#bnf_int_1258\" namespace=\"/interactions/list-of-drug-interactions/antivirals/elvitegravir\">Elvitegravir</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP3763\" namespace=\"/drugs/emtricitabine\">emtricitabine</xref>, <xref format=\"dita\" href=\"#PHP3775\" namespace=\"/drugs/tenofovir-disoproxil\">tenofovir disoproxil</xref>, <xref format=\"dita\" href=\"#PHP106892\" namespace=\"/drugs/cobicistat\">cobicistat</xref>.</p>\n<data name=\"vtmid\">23167611000001108</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_196497339\" title=\"Pharmacokinetic enhancers\">Pharmacokinetic enhancers</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_432836609\" title=\"HIV-integrase inhibitors\">HIV-integrase inhibitors</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_149321041\" title=\"Nucleoside reverse transcriptase inhibitors\">Nucleoside reverse transcriptase inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP86671\" outputclass=\"indicationsAndDose\" rev=\"1.16\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;tablet once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86672\" outputclass=\"interactions\" rev=\"1.24\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (cobicistat, elvitegravir, emtricitabine, tenofovir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86677\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Depression and suicidal ideation (in patients with a history of psychiatric illness)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86665\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Women of child-bearing potential should use effective contraception during treatment (if using a hormonal contraceptive, it must contain norgestimate as the progestogen and at least 30&#8239;micrograms ethinylestradiol).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86673\" outputclass=\"pregnancy\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86670\" outputclass=\"hepaticImpairment\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid <i>Stribild</i>\n<tm tmtype=\"reg\"/> in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86675\" outputclass=\"renalImpairment\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>If eGFR less than 90&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, only <i>initiate</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if other treatments cannot be used (avoid <i>initiating</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if eGFR less than 70&#8239;mL/minute/1.73&#8239;m<sup>2</sup>); if eGFR less than 70&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, only <i>continue</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if potential benefit outweighs risk (discontinue <i>Stribild</i>\n<tm tmtype=\"reg\"/> if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86681\" outputclass=\"monitoringRequirements\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Test urine glucose before treatment, then every 4 weeks for 1 year and then every 3 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86661\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid antacids 4 hours before or 4 hours after taking <i>Stribild</i>\n<tm tmtype=\"reg\"/>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86685\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dispense in original container (contains desiccant).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86674\" outputclass=\"patientAndCarerAdvice\" rev=\"1.14\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundMissedDoses\">\n<title>Missed doses</title>\n<sectiondiv>\n<p>If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer <i>Stribild</i>\n<tm tmtype=\"reg\"/>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP85586-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92234\" title=\"Tablet\" namespace=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"3\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"1\" rel=\"backlink\">HIV infection</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_998\" namespace=\"/interactions/list-of-drug-interactions/antivirals/emtricitabine\" title=\"Emtricitabine\" count=\"1\" rel=\"link\">Emtricitabine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_954\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tenofovir\" title=\"Tenofovir\" count=\"1\" rel=\"link\">Tenofovir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1259\" namespace=\"/interactions/list-of-drug-interactions/cobicistat\" title=\"Cobicistat\" count=\"1\" rel=\"link\">Cobicistat</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1258\" namespace=\"/interactions/list-of-drug-interactions/antivirals/elvitegravir\" title=\"Elvitegravir\" count=\"1\" rel=\"link\">Elvitegravir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3763\" namespace=\"/drugs/emtricitabine\" title=\"EMTRICITABINE\" count=\"1\" rel=\"link\">EMTRICITABINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3775\" namespace=\"/drugs/tenofovir-disoproxil\" title=\"TENOFOVIR DISOPROXIL\" count=\"1\" rel=\"link\">TENOFOVIR DISOPROXIL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP106892\" namespace=\"/drugs/cobicistat\" title=\"COBICISTAT\" count=\"1\" rel=\"link\">COBICISTAT</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92234\" namespace=\"/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP85586",
    "outputclass": "drug",
    "rev": "1.26",
    "type": "drug",
    "namespace": "/drugs/cobicistat-with-elvitegravir-emtricitabine-and-tenofovir",
    "basename": "cobicistat-with-elvitegravir-emtricitabine-and-tenofovir",
    "title": "COBICISTAT WITH ELVITEGRAVIR, EMTRICITABINE AND TENOFOVIR",
    "interactants": [
        {
            "id": "bnf_int_998",
            "label": "Emtricitabine"
        },
        {
            "id": "bnf_int_954",
            "label": "Tenofovir"
        },
        {
            "id": "bnf_int_1259",
            "label": "Cobicistat"
        },
        {
            "id": "bnf_int_1258",
            "label": "Elvitegravir"
        }
    ],
    "constituents": [
        {
            "id": "PHP3763",
            "label": "emtricitabine"
        },
        {
            "id": "PHP3775",
            "label": "tenofovir disoproxil"
        },
        {
            "id": "PHP106892",
            "label": "cobicistat"
        }
    ],
    "vtmid": "23167611000001108",
    "drugClassification": [
        "Pharmacokinetic enhancers",
        "HIV-integrase inhibitors",
        "Nucleoside reverse transcriptase inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection",
                        "html": "HIV infection"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 tablet once daily.",
                        "html": "<p>1&#8239;tablet once daily.</p>"
                    }
                ]
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (cobicistat, elvitegravir, emtricitabine, tenofovir).",
                "html": "<p>Appendix 1 (cobicistat, elvitegravir, emtricitabine, tenofovir).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Depression and suicidal ideation (in patients with a history of psychiatric illness)",
                        "html": "Depression and suicidal ideation (in patients with a history of psychiatric illness)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Women of child-bearing potential should use effective contraception during treatment (if using a hormonal contraceptive, it must contain norgestimate as the progestogen and at least 30 micrograms ethinylestradiol).",
                "html": "<p>Women of child-bearing potential should use effective contraception during treatment (if using a hormonal contraceptive, it must contain norgestimate as the progestogen and at least 30&#8239;micrograms ethinylestradiol).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid Stribild in severe impairment.",
                "html": "<p>Avoid <i>Stribild</i>\n<tm tmtype=\"reg\"/> in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "If eGFR less than 90 mL/minute/1.73 m2, only initiate Stribild if other treatments cannot be used (avoid initiating Stribild if eGFR less than 70 mL/minute/1.73 m2); if eGFR less than 70 mL/minute/1.73 m2, only continue Stribild if potential benefit outweighs risk (discontinue Stribild if eGFR less than 50 mL/minute/1.73 m2).",
                "html": "<p>If eGFR less than 90&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, only <i>initiate</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if other treatments cannot be used (avoid <i>initiating</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if eGFR less than 70&#8239;mL/minute/1.73&#8239;m<sup>2</sup>); if eGFR less than 70&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, only <i>continue</i>\n<i>Stribild</i>\n<tm tmtype=\"reg\"/> if potential benefit outweighs risk (discontinue <i>Stribild</i>\n<tm tmtype=\"reg\"/> if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Test urine glucose before treatment, then every 4 weeks for 1 year and then every 3 months.",
                "html": "<p>Test urine glucose before treatment, then every 4 weeks for 1 year and then every 3 months.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Avoid antacids 4 hours before or 4 hours after taking Stribild .",
                "html": "<p>Avoid antacids 4 hours before or 4 hours after taking <i>Stribild</i>\n<tm tmtype=\"reg\"/>.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dispense in original container (contains desiccant).",
                "html": "<p>Dispense in original container (contains desiccant).</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundMissedDoses": [
            {
                "type": "adviceAroundMissedDoses",
                "textContent": "If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.",
                "html": "<p>If a dose is more than 18 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer Stribild .",
                "html": "<p>Patients or carers should be given advice on how to administer <i>Stribild</i>\n<tm tmtype=\"reg\"/>.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92234",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_998",
                "label": "Emtricitabine",
                "type": "interaction"
            },
            {
                "id": "bnf_int_954",
                "label": "Tenofovir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1259",
                "label": "Cobicistat",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1258",
                "label": "Elvitegravir",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP3763",
                "label": "EMTRICITABINE",
                "type": "drug"
            },
            {
                "id": "PHP3775",
                "label": "TENOFOVIR DISOPROXIL",
                "type": "drug"
            },
            {
                "id": "PHP106892",
                "label": "COBICISTAT",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92234",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}